AI Boosts Diabetic Eye Care Access - Summary - MDSpire
Clinical Guidelines

AI Boosts Diabetic Eye Care Access

Recent study highlights how integrated AI-assisted DR screening in primary care clinics can improve access and decrease disparity

  • May 5, 2026

  • 3 min

Share

A study from Johns Hopkins Medicine reveals that utilizing autonomous artificial intelligence (AI) for diabetic retinopathy (DR) screening may significantly elevate screening rates and improve access to specialist care. An analysis involving 3,745 diabetic adults demonstrated that those screened via AI were more likely to consult with eye care specialists compared to those referred traditionally. This method particularly benefited historically underserved groups, such as African-American patients, by embedding DR detection within routine primary care, thereby reducing barriers to follow-up care. Despite these promising outcomes, the authors caution that improved screening alone cannot rectify disparities without ensuring access to further ophthalmic evaluations and treatments.

Original Source(s)

AI Boosts Diabetic Eye Care Access

  • May 5, 2026

Related Content

Surgical Confidence with Hydrus®

Nishani Amerasinghe shares surgical tips and pearls for the Hydrus® Microstent

  • May 5, 2026

  • 5 min
Cell Therapy Trial Targets Corneal Disease

Aurion Biotech launches phase 3 trial for corneal endothelial cell therapy

  • May 4, 2026

  • 2 min
The Art of Ophthalmology 2026

Showcasing artwork and images from across the spectrum of ophthalmology